Pallas Capital Advisors LLC Acadia Pharmaceuticals Inc Transaction History
Pallas Capital Advisors LLC
- $2.43 Billion
- Q2 2025
A detailed history of Pallas Capital Advisors LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 12,664 shares of ACAD stock, worth $273,162. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,664Holding current value
$273,162% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
356Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$925 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$328 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$260 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$184 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$151 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.49B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...